Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2008, Vol. 13 ›› Issue (3): 254-258.

Previous Articles     Next Articles

Construction of recombinant adenovirus carrying Kringle 5 gene and effects on the survival of pulmonary carcinoma bearing mice

LIU Yan1, LIU Fang3, YE Xun3, DONG Ji-bin2, LU Qin3, ZHAO Yi3, LI Qiu-hua1, CHEN Hongzhuan3   

  1. 1Department of Ophthalmology, Fudan University Affiliated Huashan Hospital, Shanghai 200040, China;
    2Department of Biochemistry, School of Pharmacy, Fudan University, Shanghai 200032, China;
    3Department of Pharmacology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Received:2007-10-09 Revised:2007-10-09 Published:2020-10-15

Abstract: AIM: To construct the recombinant adenovirus containing human plasminogen Kringle 5 (K5)gene, then observe the secreted expression and effect of K5 protein on TC-1 tumors. METHODS: We cloned K5 gene into the genome of replication-defective adenovirus by virus recombination technology;the K5 RNA expression was evaluated by RT-PCR;the K5 protein secreted expression was determined by Immunoprecipitation andWestern blotting;the effect of K5 was observed in xenograft lung cancr mice model;and the tumor microvascular density (MVD)was counted. RESULTS: The recombined adenovirus Ad-EF1α-K5 was constructed successfully and was expressing in the levels of both mRNA and protein.In the mice lung cancer xenograft model, the recombinant adenovirus can delay the growth of established TC-1 tumors and decrease the MVD. CONCLUSION: Recombinant adenovirus vectors Ad-EF1α-K5 can efficiently express protein K5 and inhibit tumor growth in the mice lung cancer xenograft model.The effect may related to inhibitory effect on angiogenesis.

Key words: adenovirus, Kringle 5, angiogenesis, TC-1

CLC Number: